Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

The future of gene therapy.

Nabel GJ.

Ernst Schering Res Found Workshop. 2003;(43):1-16. Review. No abstract available.

PMID:
12894447
2.

[Strategies for gene therapy].

Kaneda Y.

Nihon Rinsho. 2005 Dec;63 Suppl 12:486-90. Review. Japanese. No abstract available.

PMID:
16416840
3.

Lentiviral vectors for gene therapy of heart disease.

Higuchi K, Medin JA.

J Cardiol. 2007 Jan;49(1):1-11. Review.

PMID:
17269208
4.

Gene therapy for cardiovascular disorders: is there a future?

Metcalfe BL, Sellers KW, Jeng MJ, Huentelman MJ, Katovich MJ, Raizada MK.

Ann N Y Acad Sci. 2001 Dec;953:31-42. Review.

PMID:
11795421
5.

Genetic therapies for cardiovascular diseases.

Melo LG, Pachori AS, Gnecchi M, Dzau VJ.

Trends Mol Med. 2005 May;11(5):240-50. Review.

PMID:
15882612
6.

Gene therapy approaches to cardiovascular disease.

Jones JM, Koch WJ.

Methods Mol Med. 2005;112:15-35. Review.

PMID:
16010008
7.

Nonviral vectors for cardiovascular gene delivery.

Wolff JA, Herweijer H.

Ernst Schering Res Found Workshop. 2003;(43):41-59. Review. No abstract available.

PMID:
12894450
8.

Gene therapy in cardiovascular disease: state of the art.

White DC, Milano CA.

Ann Surg. 2003 Dec;238(6 Suppl):S90-7; discussion S98-9. Review. No abstract available.

PMID:
14703749
9.

Gene therapy in cardiovascular disorders.

Wadhwa S.

J Assoc Physicians India. 2001 May;49:538-42. Review. No abstract available.

PMID:
11361269
10.

Does gene therapy become pharmacotherapy?

Morishita R, Aoki M, Ogihara T.

Exp Physiol. 2005 May;90(3):307-13. Epub 2005 Mar 18. Review.

11.

Antioxidant gene therapy for cardiovascular disease: current status and future perspectives.

Levonen AL, Vähäkangas E, Koponen JK, Ylä-Herttuala S.

Circulation. 2008 Apr 22;117(16):2142-50. doi: 10.1161/CIRCULATIONAHA.107.718585. Review.

12.

[Current status of gene therapy in oversea countries].

Tani K.

Nihon Rinsho. 2005 Dec;63 Suppl 12:496-504. Review. Japanese. No abstract available.

PMID:
16416842
13.

Development of targeted viral vectors for cardiovascular gene therapy.

Nicklin SA, Baker AH.

Genet Eng (N Y). 2003;25:15-49. Review. No abstract available.

PMID:
15260232
14.

Implications of human genome and modern cell biology research in management of cardiovascular diseases.

Ghosh K, Khare A, Shetty S.

Indian Heart J. 2005 May-Jun;57(3):270-3. Review. No abstract available.

PMID:
16196190
15.

Designing gene delivery vectors for cardiovascular gene therapy.

Baker AH.

Prog Biophys Mol Biol. 2004 Feb-Apr;84(2-3):279-99. Review.

PMID:
14769440
16.

Modification of cardiovascular ion channels by gene therapy.

Telemaque S, Marsh JD.

Expert Rev Cardiovasc Ther. 2009 Aug;7(8):939-53. doi: 10.1586/erc.09.76. Review.

PMID:
19673672
17.

Prospects for gene therapy in cardiovascular disease.

Lafont A, Guérot C, Lemarchand P.

Eur Heart J. 1996 Sep;17(9):1312-7. Review. No abstract available.

PMID:
8880015
18.

Gene therapy for vascular disease.

Heistad DD.

Vascul Pharmacol. 2006 Nov;45(5):331-3. Epub 2006 Aug 18. Review.

PMID:
16996317
19.

Ten steps to gene therapy for cardiovascular diseases.

Rios CD, Chu Y, Davidson BL, Heistad DD.

J Lab Clin Med. 1998 Aug;132(2):104-11. Review. No abstract available.

PMID:
9708571
20.

[Cardiac and vascular gene therapy in cardiology. Current status and future prospects].

Kalka C, Isner JM.

Internist (Berl). 2002 Apr;43 Suppl 1:S66-75. Review. German. No abstract available.

PMID:
11993001

Supplemental Content

Support Center